HPV DNA is associated with a subset of Schneiderian papillomas but does not correlate with p16(INK4a) immunoreactivity.
This study investigated the role of human papillomavirus (HPV) in Schneiderian papillomas (SPs) to determine whether HPV is associated with the pathogenesis of particular histologic subtypes and whether p16(INK4a) can be used as a surrogate marker for HPV detection. Twenty-seven papilloma specimens (19 inverted [IPs], 6 exophytic [EPs], 1 oncocytic [OP] and 1 mixed) were collected from 23 patients. Purified SP DNA extracts were tested for HPV by PCR using GP5 +/GP6 + primers; HPV genotyping was performed by dot blot hybridization. PCR positive specimens were screened for HPV by biotinyl-tyramide-based chromogenic in situ hybridization (CISH). Immunohistochemsistry (IHC) for the HPV L1 capsid protein and for p16(INK4a) was performed on all specimens. HPV was detected by PCR in 16/27 (59.3%) SPs; 9/19 (47.4%) IPs; 6/6 (100%) EPs [p = 0.051], and 1/1 (100%) mixed SP. HPV was not detected in the single OP. High risk genotypes were detected in 4/9 IPs (44.4%) and 0/6 EPs (0%) [p = 0.10]. Seven of 16 PCR positive SPs were also CISH positive for HPV: 5/6 EPs (83.3%) and 1/9 IP (11.1%) [p = 0.01]. IHC for the L1 capsid protein was positive in 2 SPs (1 EP and 1 mixed). p16(INK4a) staining was seen in 14/16 (87.5%) PCR positive SPs and in 10/11 (90.9%) PCR negative SPs (p = 1.00). In summary, this study demonstrates a strong association between HPV and EPs, however, its role in IPs remains less well-defined. Further, p16(INK4a) is not a useful surrogate marker for HPV detection across the various SPs.
Shah
A A
AA
Department of Pathology, University of Vermont, Burlington, VT, USA.
Evans
M F
MF
Adamson
C S-C
CS
Peng
Z
Z
Rajendran
V
V
Cooper
K
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000378:metabolism; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism*; D004279:DNA, Viral; D005260:Female; D006801:Humans; D017403:In Situ Hybridization; D008297:Male; D008875:Middle Aged; D009297:Nasal Mucosa / Q000378:metabolism / Q000473:pathology / Q000821:virology*; D009669:Nose Neoplasms / Q000473:pathology / Q000821:virology*; D018308:Papilloma, Inverted / Q000378:metabolism / Q000473:pathology / Q000821:virology*; D027383:Papillomaviridae / Q000235:genetics*; D030361:Papillomavirus Infections / Q000378:metabolism / Q000473:pathology / Q000821:virology*; D016133:Polymerase Chain Reaction; D055815:Young Adult
D014408:Biomarkers, Tumor; D019941:Cyclin-Dependent Kinase Inhibitor p16; D004279:DNA, Viral
Am J Surg Pathol. 2000 Mar;24(3):429-41
10716158
Hum Pathol. 1991 Jun;22(6):550-6
1650753
Laryngoscope. 2002 Aug;112(8 Pt 1):1372-7
12172247
J Clin Pathol. 2003 Mar;56(3):174-81
12610092
Nat Rev Cancer. 2002 May;2(5):342-50
12044010
Laryngoscope. 1995 Jan;105(1):66-71
7837916
Br J Exp Pathol. 1976 Aug;57(4):361-76
183803
Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1042-50
18248389
Mod Pathol. 2008 Apr;21(4):376-86
18223558
Mod Pathol. 2008 Mar;21(3):231-7
18157089
Laryngoscope. 1999 Jan;109(1):21-6
9917034
BMC Clin Pathol. 2005 Nov 16;5:10
16288661
Mod Pathol. 2002 Mar;15(3):279-97
11904343
Am J Surg Pathol. 1990 Apr;14(4):364-9
2321700
Otolaryngol Head Neck Surg. 1995 Jul;113(1):49-55
7603721
Rhinology. 1997 Jun;35(2):74-8
9299655
Mod Pathol. 2002 Dec;15(12):1339-47
12481016
BMC Clin Pathol. 2003 Jun 11;3(1):2
12801424
Am J Pathol. 2003 Mar;162(3):747-53
12598309
Ann Otol Rhinol Laryngol. 1971 Apr;80(2):192-206
4323842
Am J Clin Pathol. 1996 Oct;106(4):475-82
8853035
J Pathol. 2004 Jan;202(1):1-4
14694515
Laryngoscope. 1995 Mar;105(3 Pt 1):282-8
7877417
Laryngoscope. 1962 Dec;72:1784-97
13938967
Acta Otolaryngol. 1987 Sep-Oct;104(3-4):334-41
2823523
Head Neck Pathol. 2008 Jun;2(2):49-59
20614323
Hum Pathol. 1986 Apr;17(4):393-400
3957337
Adv Anat Pathol. 2006 Jul;13(4):190-4
16858153